Alcohol Health Services Research (R34 Clinical Trial Optional)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Sep 3, 2026
Can you apply?
This grant is for researchers and research institutions seeking to develop and test interventions for alcohol-related health services and treatment outcomes. Eligible applicants typically include academic institutions, research hospitals, federally qualified health centers, nonprofit research organizations, and state/local health agencies. The R34 mechanism is designed for early-stage research planning and piloting before full-scale clinical trials, with the option to include clinical trial components. Applicants must have institutional research infrastructure, IRB approval capability, and demonstrated ability to conduct NIH-funded research. Geographic scope is U.S. and territories. Activities supported include formative research, intervention development, feasibility studies, and pilot testing of alcohol treatment or prevention interventions.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- SF-424 R&R (NIH research and related activities form)
- Project narrative/research narrative (6-15 pages)
- Specific aims (typically 1 page)
- Research methodology and timeline
- Budget and budget justification
- Biographical sketches (NIH format) for key personnel
- Letters of organizational support and institutional commitment
- Institutional review board (IRB) approval or approval letter if research involves human subjects
- Letters of support from collaborators, clinical partners, or community members
- Current and pending support documentation
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.273 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$125,900,663
-
$34,675,742
-
$34,469,501
-
$33,261,336
-
$32,897,567
-
$31,652,514
-
$30,394,602
-
$30,371,564
-
$29,223,384
-
$29,195,978
Top States by Funding
- CA 16 awards $250.8M
- NY 3 awards $165.6M
- OR 7 awards $96.3M
- NC 4 awards $67.1M
- IN 3 awards $61.9M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.273). How funding has trended year over year.
| 2024 | $430,377,419 | |
| 2025 | $429,906,735 | |
| 2026 est. | $12,401,560 |
FAQ
Who is eligible to apply for this R34 grant?
Researchers at accredited academic institutions, medical centers, hospitals, health departments, and nonprofit research organizations with appropriate institutional infrastructure. Individual researchers must be affiliated with eligible institutions. Foreign institutions may participate but the applicant organization must be U.S.-based.
What is the R34 mechanism and how is it different from R01?
R34 is a planning and pilot funding mechanism intended for early-stage research to develop and test interventions before submitting for full R01 funding. It typically funds smaller studies over 2 years and emphasizes feasibility, not large-scale efficacy testing.
Can I include a clinical trial in my R34 application?
Yes, this FOA explicitly notes clinical trial as optional. You may conduct a small pilot trial, but full-scale efficacy trials are better suited for R01 funding. IRB approval is required before funding begins.
What documents must be included in my application?
Standard NIH forms (SF-424 R&R) plus research narrative (6-15 pages), specific aims, methodology, timeline, budget with justification, organizational capacity documentation, letters of support, and biosketch for key personnel. IRB approval letters may be required.
How competitive is this funding opportunity?
R34s are moderately competitive. Study sections review based on innovation, feasibility, team capability, and potential to advance alcohol health services research. Strong preliminary data and realistic scope increase competitiveness.
💡 Tips for applicants
- Focus on feasibility and proof-of-concept: R34s reward realistic, achievable studies that generate pilot data to justify a future R01 application. Avoid over-ambition.
- Build a strong team: Include collaborators with expertise in alcohol health services, intervention development, statistics, and implementation science. Show complementary skills through biosketches.
- Be specific about your intervention: Clearly describe what you are testing, why existing approaches are insufficient, and how your work addresses a gap in alcohol health services or treatment outcomes.
- Include meaningful community or clinical partnerships: Letters of support from treatment providers, clinics, or patient groups strengthen applications and demonstrate real-world feasibility.
- Plan for sustainability and next steps: Explain how pilot results will lead to an R01 or other follow-on funding. Show commitment to the research area beyond this grant period.
⚠️ Common mistakes
Applications often fail because they lack sufficient preliminary data or pilot work, making feasibility unclear. Applicants frequently over-scope the project, attempting clinical trials or interventions that are too ambitious for a 2-year planning grant. Another common issue is weak team composition or unclear roles, which raises concerns about the organization's capacity to execute the proposed research successfully.
Similar grants
- CLOSING SOON Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) — National Institutes of Health
- CLOSING SOON Alcohol Health Services Research (R01 Clinical Trial Optional) — National Institutes of Health
- OPEN Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) — National Institutes of Health
- OPEN Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) — National Institutes of Health
- CLOSING SOON Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) — National Institutes of Health